Leukemia News

Precision oncology therapies requiring biomarker testing comprised 43% of all FDA oncology drug approvals between 1998 and 2022, study results published in Cancer Discovery showed.

The FDA announced several regulatory actions.

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Bioengineering company Ossium Health, which is developing the first bank of bone marrow collected from organ donors, has partnered with the National Marrow Donor Program/Be The Match to increase access to lifesaving bone marrow.

Healio spoke with Gwen Nichols, MD, about unmet needs in CML.

Healio spoke with Gwen Nichols, MD, to discuss survivorship in CML patients.

Healio spoke with Gwen Nichols, MD, to discuss how to approach CML treatment in pediatric patients.

Healio spoke with Gwen Nichols, MD, about treatment options currently available in CML.

Healio spoke with Gwen Nichols, MD, about when to consider a CML diagnosis.

Novel targeted therapies have become standard treatment for chronic lymphocytic leukemia due to their ability to delay progression of this slow-growing malignancy.